M&G Investment Management LTD Bei Gene, Ltd. Transaction History

M&G Investment Management LTD

$28.2 Trillion
Q4 2023

A detailed history of M&G Investment Management LTD transactions in Bei Gene, Ltd. stock. As of the latest transaction made, M&G Investment Management LTD holds 173,266 shares of BGNE stock, worth $29.9 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

173,266

Previous 173,266 -0.0%

Holding current value

$29.9 Million

Previous $31.2 Billion -0.0%

% of portfolio

0.11%

Previous 0.11%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 08, 2024	BUY	$158.67 - $201.58 $1.16 Million - $1.48 Million	7,325 Added 4.41%	173,266 $31.2 Billion
Q3 2023 Nov 13, 2023	BUY	$179.87 - $225.13 $3.68 Million - $4.61 Million	20,455 Added 14.06%	165,941 $29.9 Billion
Q2 2023 Aug 01, 2023	BUY	$178.3 - $266.78 $1.4 Million - $2.09 Million	7,844 Added 5.7%	145,486 $25.9 Billion
Q1 2023 May 11, 2023	BUY	$215.53 - $274.5 $2.81 Million - $3.58 Million	13,038 Added 10.46%	137,642 $29.7 Million
Q4 2022 Jan 27, 2023	BUY	$125.51 - $229.3 $2.98 Million - $5.44 Million	23,721 Added 23.51%	124,604 $0

Q3 2022 Nov 01, 2022	SELL	$131.8 - $202.24 $1.45 Million - $2.22 Million	-10,977 Reduced 9.81%	100,883 $13.6 Million
Q2 2022 Aug 25, 2022	BUY	$121.11 - $216.05 $5.7 Million - $10.2 Million	47,031 Added 72.55%	111,860 $18.1 Million
Q1 2022 May 13, 2022	BUY	$146.52 - $269.56 $7.52 Million - $13.8 Million	51,310 Added 379.54%	64,829 $12.3 Million
Q4 2021 Jan 18, 2022	SELL	$248.56 - $389.34 $1.34 Million - $2.09 Million	-5,373 Reduced 28.44%	13,519 $3.66 Million
Q3 2021 Nov 09, 2021	BUY	$249.6 - $403.14 $2.05 Million - $3.31 Million	8,206 Added 76.79%	18,892 $6.86 Million
Q2 2021 Aug 16, 2021	BUY	$292.75 - $367.01 $16,394 - $20,552	56 Added 0.53%	10,686 $3.67 Million
Q1 2021 May 12, 2021	SELL	$260.64 - $382.12 $3.91 Million - $5.74 Million	-15,016 Reduced 58.55%	10,630 $3.7 Million
Q4 2020 Feb 02, 2021	BUY	$221.31 - $316.61 $580,717 - $830,784	2,624 Added 11.4%	25,646 $6.62 Million
Q3 2020 Oct 26, 2020	SELL	$189.18 - $286.44 $3.62 Million - $5.48 Million	-19,141 Reduced 45.4%	23,022 $6.58 Million
Q2 2020 Jul 22, 2020	BUY	$123.9 - $195.41 $3.15 Million - $4.96 Million	25,391 Added 151.39%	42,163 $7.93 Million
Q1 2020 Apr 09, 2020	BUY	$121.84 - $173.19 $1.16 Million - $1.64 Million	9,497 Added 130.54%	16,772 $2.06 Million
Q4 2019 Jan 28, 2020	BUY	$115.78 - $208.34 $842,299 - $1.52 Million	7,275 New	7,275 $1.21 Million

Others Institutions Holding BGNE

# of Institutions

216

Shares Held

45.1M

Call Options Held

76.5K

Put Options Held

72.3K

View Full List

About BeiGene, Ltd.

Ticker BGNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,700,000
Market Cap $17.9B
Description
BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...

More about BGNE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of M&G Investment Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on M&G Investment Management LTD with notifications on news.

Account

M&G Investment Management LTD Bei Gene, Ltd. Transaction History